Eribulin Mesylate Injection
Product Images NDC 0781-3391

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 0781-3391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical_structure (Eribulin 01)

FDA Label Image

Figure-1 (Eribulin 02)

This text provides information on the proportion of patients alive over a certain period of time in a study comparing Eribulin Mesylate with a control group. The number of patients at risk is also mentioned at different time points in months.*

FDA Label Image

Figure-2 (Eribulin 03)

This text provides information about the survival probability of two treatments, Eribulin Mesylate and Dacarbazine. The number of subjects at risk for each treatment group is also indicated for different time points.*

FDA Label Image

Carton (Eribulin 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.